Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human NR2C1 Antibodies:
anti-Mouse (Murine) NR2C1 Antibodies:
anti-Rat (Rattus) NR2C1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal NR2C1 Primary Antibody for IP, WB - ABIN4361558
Olivares, Han, Soto, Flattery, Marini, Molemma, Haider, Escher, DeAngelis, Haider: The nuclear hormone receptor gene Nr2c1 (Tr2) is a critical regulator of early retina cell patterning. in Developmental biology 2017
DRED is a 540 kDa complex containing the nuclear orphan receptors TR2 and TR4, which form a heterodimer that binds to the epsilon and gamma globin promoter DR1 sites. TR2 & 4 mRNAs are expressed at all stages of murine and human erythropoiesis.
TR2 that may exert an important repressor in regulating ER activity in mammary glands.
TR2 and TR4 (show NR2C2 Antibodies) can have distinct functions. Existence of differential and bi-directional regulation between PPAR alpha (show PPARA Antibodies) and TR2/TR4 (show NR2C2 Antibodies). Possible roles in PPAR alpha (show PPARA Antibodies) signaling pathway in human keratinocytes.
TR2 may function as a negative modulator to suppress androgen receptor function in prostate cancer. Further studies on how to control TR2 function may result in the ability to modulate AR function in prostate cancer.
The NF1-A (show NFIA Antibodies) transcription factor plays an important role in the transcriptional activation of the TR2 gene expression via a promoter activating cis (show CISH Antibodies)-element.
This study supports a role for Nr2c1 in defining the biphasic period of retinal development and specifically influencing the early phase of retinal cell fate.
Nr2c1 may be a candidate for mediating parallel adaptive changes in cranial neural sensory specializations such as the olfactory epithelium, retina and mystacial vibrissae and in non-neural craniofacial features including teeth
TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes
in adult erythroid cells, TR2/TR4 (show NR2C2 Antibodies) bind to the embryonic beta-type globin promoters but not to the adult beta-globin (show HBB Antibodies) promoter.
TR2 may not play essential roles in spermatogenesis and normal testis development, function, and maintenance. Alternatively, the roles of TR2 may be redundant and could be played by other close members of the nuclear receptor superfamily (TR2 receptor)
These results suggest a SUMOylation-dependent partitioning and differential coregulator recruitment contribute to the maintenance of a homeostatic supply of activating, Tr2, thus fine-tuning Oct4 (show POU5F1 Antibodies) expression and regulating stem-cell proliferation.
Silencing of the embryonic and fetal beta globin (show HBB Antibodies) genes is delayed in erythroid cells of Tr2 and Tr4 (show NR2C2 Antibodies) null mutant mice, whereas in transgenic mice expressing dominant-negative TR4 (show NR2C2 Antibodies) (dnTR4), human embryonic epsilon-globin (show HBe1 Antibodies) is activated in erythroid cells.
TR2 and TR4 (show NR2C2 Antibodies) orphan nuclear receptors repress Gata1 (show GATA1 Antibodies) transcription.
Retinoic acid-stimulated sequential phosphorylation, PML (show PML Antibodies) recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 (show POU5F1 Antibodies) expression
This gene encodes a nuclear hormone receptor characterized by a highly conserved DNA binding domain (DBD), a variable hinge region, and a carboxy-terminal ligand binding domain (LBD) that is typical for all members of the steroid/thyroid hormone receptor superfamily. This protein also belongs to a large family of ligand-inducible transcription factors that regulate gene expression by binding to specific DNA sequences within promoters of target genes. Multiple alternatively spliced transcript variants have been described, but the full-length nature of some of these variants has not been determined.
nuclear receptor subfamily 2, group C, member 1
, Nuclear receptor subfamily 2 group C member 1
, TR2 nuclear hormone receptor
, nuclear receptor subfamily 2 group C member 1
, nuclear receptor subfamily 2, group C isoform
, orphan nuclear receptor TR2
, developmental orphan receptor 2
, developmental orphan receptor 2-A
, nuclear receptor subfamily 2 group C member 1-A
, orphan nuclear receptor TR2-A
, testicular receptor 2-A
, 80-3 cNDA
, early embryonic nuclear receptor
, nuclear receptor subfamily 2, group H, member 1
, orphan receptor, TR2-11
, testicular receptor 2
, pregnancy specific beta-1-glycoprotein 4